Selected article for: "acute stage and infection acute stage"
Author: Binet, Quentin; Goffinet, Céline; Etogo-Asse, Frédérique-Estelle; Shaza, Leila
Title: Nonbacterial thrombotic endocarditis in a patient with gastric cancer and SARS-CoV-2 infection
  • Cord-id: yxjw9dxh
  • Document date: 2021_4_9
    • ID: yxjw9dxh
    Snippet: Nonbacterial thrombotic endocarditis, formerly known as marantic endocarditis, is a very rare complication of advanced malignancy and other hypercoagulable states in which sterile, fibrin vegetations develop on heart valve leaflets. The most common malignancies associated with this entity are lung, pancreatic and gastric cancer. It has also been described as a presentation of COVID-19, which is known to be frequently complicated with coagulopathy and thromboembolic events. We report the case of
    Document: Nonbacterial thrombotic endocarditis, formerly known as marantic endocarditis, is a very rare complication of advanced malignancy and other hypercoagulable states in which sterile, fibrin vegetations develop on heart valve leaflets. The most common malignancies associated with this entity are lung, pancreatic and gastric cancer. It has also been described as a presentation of COVID-19, which is known to be frequently complicated with coagulopathy and thromboembolic events. We report the case of a 62 year-old female patient newly diagnosed with stage IV gastric cancer and acute SARS-CoV-2 infection, presenting with confusion and homonymous hemianopsia in the setting of multiple acute ischemic strokes complicating a nonbacterial thrombotic mitral endocarditis. Herein, we discuss the underlying pathophysiology and make the hypothesis that SARS-CoV-2 infection could have participated in the pathogenesis of nonbacterial thrombotic endocarditis in our patient suffering from a gastric cancer.

    Search related documents:
    Co phrase search for related documents
    • abdominal pain and additional risk: 1, 2, 3, 4
    • abdominal pain and lmwh low molecular weight heparin: 1
    • abdominal pain and low molecular weight: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • abdominal pain and low molecular weight heparin: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • abdominal pain and lupus erythematosus: 1, 2, 3, 4
    • abdominal pain and magnetic resonance: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • active cancer and acute sars infection: 1, 2, 3, 4, 5, 6
    • active cancer and additional risk: 1, 2, 3, 4, 5, 6, 7, 8
    • active cancer and magnetic resonance: 1, 2, 3